>Unless Avastin is approved in the UK by the National >Institute for Clinical Excellence (Nice) it will not be >universally available within the NHS. But because >Genentech declines to apply for a licence for this use > of Avastin, Nice cannot consider it this is a real problem here. It happened with Herceptin for use in early breast cancer, too (but why the drug manufacturers didn't initially apply for a licence is unclear in that case). ----- Original Message ----- From: "Andy Amago" <aamago@xxxxxxxxxxxxx> To: <lit-ideas@xxxxxxxxxxxxx> Sent: Monday, June 19, 2006 4:25 PM Subject: [lit-ideas] Re: Genentech tries to block effective medicine in order to profit > > [Original Message] > > From: Andreas Ramos <andreas@xxxxxxxxxxx> > > To: Lit-Ideas <lit-ideas@xxxxxxxxxxxxx> > > Date: 6/18/2006 10:43:05 PM > > Subject: [lit-ideas] Genentech tries to block effective medicine in order > to profit > > ------------------------------------------------------------------ To change your Lit-Ideas settings (subscribe/unsub, vacation on/off, digest on/off), visit www.andreas.com/faq-lit-ideas.html